Target intelligence / Profile preview

Plasmodium falciparum heme detoxification system (PfHDS) (PfHDS)

Target
PfHDS
Molecular classification
Enzyme, Protein-ligand complex, Metabolic pathway
01

Overview

The Plasmodium falciparum heme detoxification system is a critical metabolic pathway located within the parasite's acidic food vacuole (Coronado et al., 2014, Toxins). During the intraerythrocytic stage of its life cycle, the parasite ingests and degrades host hemoglobin to obtain essential amino acids, a process that releases large quantities of toxic ferriprotoporphyrin IX, also known as free heme (Sullivan, 2002, Int J Parasitol). To prevent the lethal oxidative damage and membrane disruption caused by free heme, the parasite utilizes specialized proteins, including the Heme Detoxification Protein (HDP) and Histidine-Rich Proteins (HRPs), to catalyze the sequestration and crystallization of heme into an insoluble, chemically inert pigment called hemozoin (Jani et al., 2008, PLoS Pathogens). This detoxification mechanism is the primary therapeutic target for several major classes of antimalarial drugs, most notably the quinolines (e.g., chloroquine, quinine) and artemisinins (WHO, 2023, Malaria Guidelines). These drugs act by either inhibiting the biocrystallization process or reacting with heme to form toxic adducts, ultimately leading to parasite death through oxidative stress and cellular lysis (NCBI, 2022, Malaria Parasite Heme Detoxification). The system is also central to the study of antimalarial resistance, as mutations in transporters like PfCRT can reduce drug accumulation at the site of heme detoxification (UniProt, 2024, Q8I2V9).

Other names
Hemozoin formation pathwayHeme-protein complexFerriprotoporphyrin IX detoxificationHemoglobin degradation pathwayMalaria pigment formationHeme detoxification protein (HDP)Histidine-rich protein 2 (HRP2)
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin and formation of toxic drug-heme complexes leading to oxidative stress and membrane damage.

03

Biological functions

Heme crystallizationHemoglobin catabolismDetoxificationIron homeostasis
04

Disease associations

InfectionMalaria
05

Safety considerations

Drug resistance (PfCRT and PfMDR1 mutations)RetinopathyQT prolongationCinchonismNeurotoxicity
06

Interacting drugs

Chloroquine

8 more in the full profile.

07

Biomarkers

Plasmodium falciparum histidine-rich protein 2 (PfHRP2)Plasmodium falciparum lactate dehydrogenase (pLDH)

Beyond the preview

Go deeper on Plasmodium falciparum heme detoxification system (PfHDS) (PfHDS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum heme detoxification system (PfHDS) (PfHDS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call